This study investigated the messenger RNA (mRNA) expression levels of four genes (AHR, FFAR2, FXR, and TGR5) in patients with COVID-19, stratified by the presence or absence of metabolic-associated fatty liver disease (MAFLD) (Figure 2). This evidence concerns the gene FFAR2 and fatty liver disease.